Search

Your search keyword '"Rosenberg, Steven"' showing total 3,668 results

Search Constraints

Start Over You searched for: Author "Rosenberg, Steven" Remove constraint Author: "Rosenberg, Steven"
3,668 results on '"Rosenberg, Steven"'

Search Results

101. IL-15 Enhances the in vivo Antitumor Activity of Tumor-Reactive CD8 + T Cells

105. Cancer Regression and Autoimmunity Induced by Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade in Patients with Metastatic Melanoma

108. Mathai-Quillen forms and Lefschetz theory

109. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study

110. Cancer Regression and Autoimmunity in Patients after Clonal Repopulation with Antitumor Lymphocytes

112. Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

113. Nonlocal invariants in index theory

114. Bounded and $L^2$ Harmonic Forms on Universal Covers

117. Risk factors and clinical correlates of sensory dysfunction in preschool children with and without autism spectrum disorder.

118. Brief Report: Prevalence of Self-Injurious Behaviors among Children with Autism Spectrum Disorder--A Population-Based Study

119. Homotopy and Homology Vanishing Theorems and the Stability of Stochastic Flows

122. Traces and Characteristic Classes in Infinite Dimensions

124. Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers

126. Cell surface marker-based capture of neoantigen-reactive CD8+T-cell receptors from metastatic tumor digests

127. Supplementary Figures from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

128. Supplementary Table 4 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

129. Supplementary Data from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors

130. Supplementary Figure from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors

133. Supplementary Figure 5 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

134. Supplementary Table 3 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

135. Supplementary Tables 1 and 2 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

137. Data from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors

138. Data from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

139. Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers

140. Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers

141. Supplementary Movies 7-9 from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma

142. Supplementary Figures from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers

143. Supplementary Movies 4-6 from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma

144. Data from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma

145. Supplementary Table 1 from Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens

146. Supplementary figures 1 through 15 and Supplementary Tables 1 through 5 from Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor

147. Supplementary Movies 1-3 from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma

148. Supplementary Figure 1 from Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens

149. Supplementary methods from Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma

150. Data from Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor

Catalog

Books, media, physical & digital resources